You are here: Industry Insights > CAR

News List

Bristol-Myers Squibb’s Abecma gets approval in Japan for multiple myeloma ExpressPharma
January 24, 2022
The approval for Abecma is based on data obtained from the Phase II Study BB2121-MM-001 and the Phase I Study CRB-401.
JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building prnasia
January 10, 2022
JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products...
'Own' immune cells to target infectious diseases including COVID-19 worldpharmanews
April 26, 2020
The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS).
Daiichi Sankyo submits application for CAR T therapy axicabtagene ciloleucel to treat patients with certain relapsed/refractory B-cell lymphomas in Japan pharmaceutical-business-review
April 02, 2020
Daiichi Sankyo announced that it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW).
CAR macrophages go beyond T cells to fight solid tumors worldpharmanews
March 25, 2020
Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors.
Twins' Deaths in Hot Car Highlight a Preventable Tragedy drugs
July 31, 2019
It's happened again: A seemingly loving parent forgets a small child -- in this case two children -- in the back seat of a car on a hot day, with tragic results.
Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug americanpharmaceuticalreview
March 13, 2017
Endocyte, a developer of targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, announced their plan to collaborate with Seattle Children’s Research Institute and